Afrasiabi, A., Bocking, W. J., Schibeci, S. D., Law, S. P. L., Fewings, N. L., Lin, M., . . . Parnell, G. P. (2026). Epstein‐Barr Virus Transformed B Cells From Systemic Lupus Erythematosus and Multiple Sclerosis Patients Differ in EBV Lytic and Latency Marker Expression. Immunity, Inflammation & Disease, 14(3), 1. https://doi.org/10.1002/iid3.70411
Chicago Style (17th ed.) CitationAfrasiabi, Ali, et al. "Epstein‐Barr Virus Transformed B Cells From Systemic Lupus Erythematosus and Multiple Sclerosis Patients Differ in EBV Lytic and Latency Marker Expression." Immunity, Inflammation & Disease 14, no. 3 (2026): 1. https://doi.org/10.1002/iid3.70411.
MLA (9th ed.) CitationAfrasiabi, Ali, et al. "Epstein‐Barr Virus Transformed B Cells From Systemic Lupus Erythematosus and Multiple Sclerosis Patients Differ in EBV Lytic and Latency Marker Expression." Immunity, Inflammation & Disease, vol. 14, no. 3, 2026, p. 1, https://doi.org/10.1002/iid3.70411.